Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators

被引:3
|
作者
Miwa, Naoyuki [1 ]
Nagata, Yasutoshi [1 ]
Yamaguchi, Tetsuo [1 ]
Nagase, Masashi [1 ]
Sasaki, Takeshi [2 ]
Nozato, Toshihiro [1 ]
Ashikaga, Takashi [1 ]
Goya, Masahiko [3 ]
Hirao, Kenzo [4 ]
机构
[1] Japanese Red Cross Musashino Hosp, Dept Cardiol, 1-26-1 Kyonancho, Tokyo 1808610, Japan
[2] Disaster Med Ctr, Dept Cardiovasc Med, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Dept Cardiovasc Med, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan
关键词
Brugada syndrome; Defibrillator screening; Holler monitoring; Subcutaneous implantable cardioverter-defibrillator; Sudden cardiac death; BRUGADA SYNDROME; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; ELECTROCARDIOGRAM; ARRHYTHMIAS; PREVALENCE; CANDIDACY; EFFICACY; PATTERN; SAFETY;
D O I
10.1016/j.hrthm.2019.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are an established therapy for preventing sudden cardiac death. However, a considerable number of patients still undergo inappropriate shocks even after conventional preim-plantation electrocardiographic (ECG) screening. OBJECTIVE This study aimed to elucidate the additional effect of diurnal variations in the QRS complex and T waves of 24-hour Hotter screening on S-ICD eligibility. METHODS Patients with transvenous ICDs who did not need pacing were selected for the study. The ECG was recorded by placing the electrodes to simulate the 3 sensing vectors of the S-ICD, with the patient in the standing and supine positions (conventional), during exercise, and during 24-hour Hotter screening. We investigated the additional discrimination of diurnal variations in patients ineligible for S-ICDs as well as characteristics of those patients. RESULTS Of the 86 patients (82% men; mean age 54 +/- 16 years) analyzed by all 3 screenings, 2 (2.3%) and 3 (3.4%) were considered ineligible by conventional and exercise screening, respectively. An additional 21 patients (24.4%) were found ineligible through Holler screening. A multivariate logistic regression analysis demonstrated that Brugada syndrome and an increased QRS duration per millisecond were associated with ineligibility (odds ratio 5.74; 95% confidence interval 1.74-20.2; P = .003 and odds ratio 1.04; 95% confidence interval 1.01-1.07; P = .007, respectively). T-wave oversensing was mostly observed during 0-6 AM, but no significant diurnal variations were observed in the incorrect QRS profiles. CONCLUSION The detection of diurnal variations through Holler monitoring in addition to conventional screening is expected to be useful for determining S-ICD eligibility.
引用
收藏
页码:913 / 920
页数:8
相关论文
共 50 条
  • [1] Clinical experience with subcutaneous implantable cardioverter-defibrillators
    Geoffrey F. Lewis
    Michael R. Gold
    Nature Reviews Cardiology, 2015, 12 : 398 - 405
  • [2] Clinical experience with subcutaneous implantable cardioverter-defibrillators
    Lewis, Geoffrey F.
    Gold, Michael R.
    NATURE REVIEWS CARDIOLOGY, 2015, 12 (07) : 398 - 405
  • [3] A SUBCUTANEOUS LEAD ARRAY FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    JORDAENS, L
    VERTONGEN, P
    VANBELLEGHEM, Y
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (07): : 1429 - 1433
  • [4] Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
    Maan, Abhishek
    Sherfesee, Lou
    Lexcen, Daniel
    Heist, E. Kevin
    Cheng, Alan
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (08) : 979 - 986
  • [5] Eligibility of CRT patients for subcutaneous implantable cardioverter defibrillators
    Giammaria, M.
    Lucciola, M.
    Amellone, C.
    Orlando, F.
    Mazzone, G.
    Lovecchio, M.
    Merlotti, G.
    Chiarenza, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 621 - 621
  • [6] Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators
    Ip, James E.
    Wu, Michael S.
    Kennel, Peter J.
    Thomas, George
    Liu, Christopher F.
    Cheung, Jim W.
    Markowitz, Steven M.
    Lerman, Bruce B.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2017, 28 (05) : 544 - 548
  • [7] Subcutaneous Implantable Cardioverter-Defibrillators: Expanding the Scope of Technology
    Saeed, Mohammad
    TEXAS HEART INSTITUTE JOURNAL, 2014, 42 (02): : 139 - 139
  • [8] Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system
    Johnson, Benjamin K.
    Garberich, Ross F.
    Henry, Timothy D.
    Katsiyiannis, William T.
    Sengupta, Jay
    Kalra, Ankur
    Hauser, Robert G.
    Lardy, Meghan E.
    Newell, Marc C.
    HEART RHYTHM, 2016, 13 (02) : 538 - 546
  • [9] TRANSVENOUS AND SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS - RADIOGRAPHIC ASSESSMENT
    DALY, BD
    CASCADE, PN
    HUMMEL, JD
    KALBFLEISCH, S
    STRICKBERGER, SA
    LANGBERG, J
    MORADY, F
    RADIOLOGY, 1994, 191 (01) : 273 - 278
  • [10] Subcutaneous implantable cardioverter-defibrillators: Function, indications and implantation
    Osswald B.
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2017, 31 (3) : 155 - 160